Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5626_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Contents
- •List of Contributors
- •Preface
- •1.2.4 Ancient Egypt
- •1.2.5 The Greeks
- •1.2.6 Arabic and Islamic Region
- •1.3 Development of Pharmacognosy in the Modern Era
- •1.4 The Relevance of Pharmacognosy in Pharmacological Research on Herbal Medicinal Products
- •1.5 Taxonomy and Botanical Authenticity
- •1.5.1 Plant Identification
- •1.5.2 Plant Nomenclature
- •1.5.3 Plant Classification
- •1.6 Phytochemistry – An Expanded Role in Traditional Medicine (History and Progress in Drug Discovery)
- •1.7 Recent Progress in Pharmacognosy and Phytochemistry
- •1.7.1 Bioactivity-guided Fractionation
- •1.7.2 Identification of Bioactive Compounds from Adulterants
- •1. Historical Overview of Pharmacognosy and Phytochemistry
- •1.1 Introduction to Pharmacognosy
- •1.2 Historical Development of Pharmacognosy
- •1.2.1 Mesopotamia Region
- •1.2.2 China
- •1.2.3 India
- •1.7.3 Omics Approach
- •1.7.4 Phytopharmacology and Mechanistic Studies
- •1.7.5 Multitargeted Approaches
- •1.7.6 Bioavailability and Drug Delivery Systems
- •1.7.7 Computational Approaches
- •1.7.8 Standardization and Quality Control
- •1.7.9 Nutraceuticals and Functional Foods
- •1.7.10 Sustainability and Conservation
- •1.7.11 Microbial Interactions and Co-cultivation
- •1.7.12 Biotechnological Approaches
- •1.7.13 Green Extraction Technology
- •1.7.14 Big Data and Artificial Intelligence
- •1.8 Conclusion
- •References
- •2. Classification of Crude Drugs of Natural Origin
- •2.1 Introduction
- •2.1.1 Definition of Crude Drugs
- •2.1.2 Importance of Classification of Crude Drugs
- •2.1.3 Early Attempts at Classification of Crude Drugs
- •2.2 Botanical Classification
- •2.2.1 Division Based on Plant Families
- •2.2.2 Importance of Taxonomy in Identifying and Categorizing Crude Drugs
- •2.2.3 Examples of Common Plant Families and Their Medicinal Representatives
- •2.3 Morphological Classification
- •2.3.1 Division Based on Plant Parts Used for Medicinal Purposes
- •2.3.1.1 Leaves
- •2.3.1.2 Roots
- •2.3.1.3 Stems
- •2.3.1.4 Bark
- •2.3.1.5 Flowers
- •2.3.1.6 Fruits
- •2.3.1.7 Seeds
- •2.3.2 Examination of Macroscopic and Microscopic Characteristics for Identification
- •2.3.3 Importance of Organoleptic Properties in Morphological Classification
- •2.4 Chemical Classification
- •2.4.1 Division Based on the Primary Active Chemical Constituents and Major Classes
- •2.4.1.1 Alkaloids
- •2.4.1.2 Glycosides
- •2.4.1.3 Volatile oils/terpenoids
- •2.4.1.4 Phenolic compounds
- •2.5 Pharmacological Classification
- •2.5.2 Relationship Between Pharmacological Activities and Chemical Constituents
- •2.6 Taxonomical Classification
- •2.6.1 Plant-Based Crude Drugs
- •2.6.2 Animal-Based Crude Drugs
- •2.6.3 Mineral-Based Crude Drugs
- •2.7 Chemotaxonomical Classification
- •2.7.1 Understanding of Chemotaxonomy
- •2.7.2 Chemotaxonomical Classes of Crude Drugs
- •2.7.2.1 Alkaloids
- •2.7.2.2 Flavonoids
- •2.7.2.3 Terpenoids
- •2.7.2.4 Phenolic Compounds
- •2.7.2.5 Glucosinolates
- •2.8 Geographical Classification
- •2.8.1 Division Based on the Geographic Origin of Crude Drugs
- •2.8.1.1 Tropical Drugs
- •2.8.1.2 Temperate Drugs
- •2.8.1.3 Arctic and Alpine Drugs
- •2.8.1.4 African Drugs
- •2.8.2 Influence of Climate, Soil, and Environmental Factors on Medicinal Properties
- •2.8.3 Examples of Region-specific Crude Drugs and Their Uses
- •2.9 Traditional and Cultural Classification
- •2.9.1 Division Based on Traditional Medicine Systems
- •2.9.2 Preservation of Traditional Knowledge in Classifying Crude Drugs
- •2.10 Modern Analytical Techniques in Classification
- •2.10.1 Use of Advanced Analytical Methods
- •2.10.1.1 Infrared Spectroscopy
- •2.10.1.2 Atomic Absorption Spectrometry
- •2.10.1.3 Inductively Coupled Plasma Mass Spectrometry
- •2.10.1.4 Chromatography Techniques
- •2.11.1.3 Taxonomic Bias and Expertise
- •2.11.2 Ethical Considerations in Classifying Endangered Plant Species
- •2.11.2.1 Data Accessibility and Accuracy
- •2.11.2.2 Taxonomic Uncertainties
- •2.11.2.3 Inadequate Resources for Research
- •2.11.2.4 Conservation Prioritization
- •2.11.2.5 Ex Situ Conservation and Access to Genetic Resources
- •2.11.2.6 Cultural and Traditional Knowledge
- •2.12 Future Perspectives
- •2.12.1 Integration of Traditional and Modern Classification Approaches for Crude Drugs
- •2.12.1.1 Incorporating Traditional Classification Systems
- •2.12.1.2 Analyzing Chemical Composition and Pharmacology
- •2.12.1.3 Bridging the Gap
- •2.12.1.4 Safety and Regulation
- •2.12.1.5 Research and Innovation
- •2.12.1.6 Holistic Patient Care
- •2.12.2 Role of Artificial Intelligence and Machine Learning
- •2.12.2.1 Data Analysis and Pattern Recognition
- •2.12.2.2 Predictive Modeling
- •2.12.2.3 Drug–Drug Interactions and Safety
- •2.12.2.4 Quality Control
- •2.12.2.5 Data Integration and Literature Mining
- •2.12.3 Emerging Trends and Innovations in the Field
- •2.13 Conclusion
- •2.13.1 Recapitulation of the Significance of Classification in Understanding Crude drugs
- •2.13.2 Importance of Accurate Classification of Crude Drugs for Safe and Effective Use in Medicine
- •2.13.3 Call to Further Research and Collaboration in Advancing Crude Drug Classification
- •References
- •2.10.2 Role of DNA Barcoding in Accurate Identification and Classification
- •2.10.3 Advantages and Challenges of Modern Techniques
- •2.11 Challenges in Classification
- •2.11.1 Overlapping Chemical Constituents in Different Classes
- •2.11.1.1 Polyploidy and Hybridization
- •2.11.1.2 Rapid Evolution and Speciation
- •3. Folk Medicine as a Source of Therapeutically Important Drugs: Evidence from Ethnobotanical Investigations
- •3.1 Introduction
- •3.1.1 Market Potential of Herbal Medicines
- •3.1.2 Early Records of Folk Medicine
- •3.1.3 Origin and Definition of Ethnobotany
- •3.1.4 History of Ethnobotany
- •3.1.5 Subdisciplines of Ethnobotany
- •3.2 Traditional Medical Systems
- •3.2.1 African Traditional Medicine
- •3.2.2 American Traditional Medicine (North, Central, and South)
- •3.2.3 Australian and Southeast Asian Medicine
- •3.2.4 Ayurvedic Medicine (Indian Traditional Medicine)
- •3.2.5 Chinese Traditional Medicine
- •3.2.6 European Medicine
- •3.2.7 Classical Arabic, North African Traditional Medicine
- •3.3 Importance of Ethnobotanical Research in Drug Discovery
- •3.4 Biological Activity of Medicinal Plants
- •3.4.1 Anticancer Activity
- •3.4.2 Antidiabetic Activity
- •3.4.3 Gastrointestinal Disorders
- •3.4.4 Respiratory Disorders
- •3.4.5 Antiviral Activity
- •3.4.6 Anti-inflammatory Activity
- •Acknowledgments
- •References
- •4. Complementary and Alternative Medicinal Systems
- •4.1 Introduction
- •4.2 Ayurveda System
- •4.2.1 History of Ayurveda
- •4.2.2 Principles of Ayurveda
- •4.2.2.1 Panchamahabhuta Siddhanta
- •4.2.2.2 Tridosha
- •4.2.2.3 Dhatus
- •4.2.2.4 Upadhatus
- •4.2.2.5 Malas
- •4.2.2.6 Srotas
- •4.2.2.7 Agni
- •4.2.2.8 Prakriti
- •4.2.3 Ayurvedic Methods of Diagnosis
- •4.2.3.1 Ayurvedic Treatment
- •4.2.4 Ayurvedic Formulations
- •4.3 Unani System
- •4.3.1 History of Unani System
- •4.3.2 Principles of Unani
- •4.3.3 Methods of Diagnosis
- •4.3.4 Treatment
- •4.3.4.1 Ilaj-Bil-Tadbeer (Regimental Therapy)
- •4.3.4.2 Ilaj-Bil-Dawa (Pharmacotherapy)
- •4.3.4.3 Ilaj-Bil-Yad (Surgical therapy)
- •4.3.5 Unani Formulations
- •4.4 Siddha System
- •4.4.1 History
- •4.4.2 Principles of Siddha
- •4.4.2.1 Five Elements
- •4.4.2.2 Seven Physical Constituents
- •4.4.2.3 Humours (Uyir Thathukkal)
- •4.4.2.4 Vaatham (Vali)
- •4.4.2.5 Pitham (Azhal)
- •4.4.2.6 Kapham (Aiyaam)
- •4.4.3 Methods of Diagnosis
- •4.4.3.1 Physical Examination of Urine
- •4.4.3.2 Pulse
- •4.4.3.3 Wrist Circumferential Sign
- •4.4.4 Treatment
- •4.4.5 Siddha Formulations
- •4.5 Homeopathy System
- •4.5.1 History
- •4.5.2 Principles of Homeopathy
- •4.5.3 Methods of Diagnosis and Treatment
- •4.6 Conclusion
- •References
- •5. Cultivation, Collection, and Preparation of Plant Drugs
- •5.1 History
- •5.2 Cultivation
- •5.2.1 Need of Medicinal Plants Cultivation
- •5.2.2 Limitation of Cultivation
- •5.2.3 Types of Cultivations
- •5.2.3.1 Sexual Propagation
- •5.2.3.2 Asexual Propagation
- •5.3 Factors Affecting Cultivation
- •5.3.1 Soil
- •5.3.2 Altitude, Temperature, and Humidity
- •5.3.3 Rainfall and Irrigation
- •5.3.4 Fertilizers and Manures in Plant Nutrition
- •5.3.5 Pests and Pest Control
- •5.3.6 Pest Control
- •5.3.6.1 Natural Method
- •5.3.6.4 Chemical Methods
- •5.4 Good Agricultural Practice
- •5.4.1 Objectives
- •5.4.2 Identification/Authentication of Cultivated Medicinal Plants
- •5.4.2.1 Medicinal Plants Selection
- •5.4.2.2 Botanical Identity
- •5.4.2.3 Specimens
- •5.4.3 Seeds and Other Propagation Materials
- •5.4.4 Site Selection
- •5.4.5 Soil
- •5.4.6 Fertilizers and Manures
- •5.4.7 Climate
- •5.4.8 Irrigation and Drainage
- •5.4.9 Plant Maintenance and Protection
- •5.4.10 Harvest
- •5.5 Good Collection Practices for Medicinal Plants
- •5.5.1 Collection Permissions
- •5.5.2 Technical Planning
- •5.5.3 Social and Ecological Impact
- •5.5.4 Selection of Medicinal Plants for Collection
- •5.6 Processing of Medicinal Plants
- •5.6.1 Primary Processing
- •5.6.2 Secondary Processing
- •5.6.2.1 Cutting/sectioning
- •5.6.2.2 Aging/sweating
- •5.6.2.3 Baking/roasting
- •5.6.2.4 Boiling/steaming
- •5.6.2.5 Stir-frying
- •5.7 Storage and Packaging
- •5.8 Sample Record for Cultivated Medicinal Plants
- •5.9 Voluntary Certification Scheme for Medicinal Plant Produce in Indian Scenario
- •5.9.1 Certification Process: For individual farmer/collector
- •References
- •6. Adulteration and Evaluation of Crude Drugs of Natural Origin
- •6.1 Introduction
- •6.2 Adulteration of Herbal Drugs
- •6.2.1 Poisonous or Deleterious Substances
- •6.2.1.1 Types of Poisonous or Deleterious Adulterants
- •6.2.2 Filth and Foreign Matter of Adulteration
- •6.2.2.1 Types and Examples
- •6.2.3 Microbiological Contamination
- •6.2.3.1 Examples of Microbiological Contamination
- •6.3 Types of Adulteration
- •6.3.1 Intentional/Deliberate Adulteration
- •6.3.2 Unknown or Incidental Adulteration
- •6.3.3 Metallic Contamination
- •6.3.4 Adulteration in Synthetic and Artificial Substances
- •6.4 Adulteration in Medicinal Plants
- •6.4.1 Reasons for Adulteration
- •6.4.2 Adulteration Caused Because of the Similar Morphology
- •6.4.3 Adulteration Caused Because of Confusion in Vernacular Names
- •6.4.4 Insufficient Basic Understanding of the Real Plant Source
- •6.5 Methods of Detection of Adulterants and Evaluation of Medicinal Herbs
- •6.5.1 Taxonomic Deciding Adulteration of Medicinal Plants
- •6.5.2 Morphological Analysis
- •6.5.3 Microscopic Analysis
- •6.5.4 Organoleptic Analysis
- •6.5.5 Qualitative and Quantitative of Phytochemical for Detection of Contaminants
- •6.5.6 Establishment of Fingerprint Profiles
- •6.5.7 Multiple Marker-based Fingerprint Profiles for Detection of Adulterants
- •6.6 Analytical Techniques in the Detection and Evaluation of Adulterants
- •6.6.1 Microscopy
- •6.6.2 Chromatographic Techniques
- •6.6.2.1 Thin-layer Chromatography
- •6.6.2.2 High-performance Liquid Chromatography
- •6.6.2.3 Gas Chromatography
- •6.6.3 Hyphenated Techniques
- •6.6.3.1 Gas Chromatography-mass Spectrometry
- •6.6.3.2 Liquid Chromatography-mass Spectrometry
- •6.6.4 Spectroscopic Methods
- •6.6.4.1 Nuclear Magnetic Resonance Spectroscopy
- •6.6.4.2 Mass Spectrometry
- •6.7 Challenges in Detection of Adulterants
- •6.8 Conclusion and Future Perspectives
- •References
- •7. Methods of Extraction
- •7.1 Introduction
- •7.2 Ideal Properties of Solvent
- •7.3 Solvents for Extraction
- •7.4 Factor Affecting Extraction Methods
- •7.5 Mechanism of Extraction
- •7.6 Methods of Extraction
- •7.6.1 Decoction
- •7.6.2 Maceration
- •7.6.2.1 Modified Macerations
- •7.6.3 Percolation
- •7.6.3.1 Imbibition
- •7.6.3.2 Maceration
- •7.6.3.3 Percolation
- •7.6.4 Soxhlation (Hot Continuous Percolation)
- •7.6.5 Extraction of Essential Oil Techniques
- •7.6.5.1 Distillation
- •7.6.5.1.1 Disadvantages of Hydro Distillation
- •7.6.5.1.2 Hydro Steam Distillation
- •7.6.5.1.3 Advantages of Hydro and Steam Distillation over Hydro Distillation
- •7.6.5.1.4 Disadvantages of Hydro and Steam Distillation over Water Distillation
- •7.6.5.1.5 Direct Steam Distillation
- •7.6.5.2 Expression
- •7.6.5.3 Ecuelle
- •7.6.5.4 Enfleurage
- •7.6.5.5 Hot Maceration Process/Digestion
- •7.6.5.6 Pneumatic Method
- •7.6.6 Phytonics
- •7.6.7 Pressurized Liquid Extraction/Accelerated Solvent Extraction
- •7.6.8 Pulsed Electric Field Extraction
- •7.6.9 Ultrasound-assisted Extraction
- •7.6.10 Microwave-assisted Extraction
- •7.6.11 Supercritical Fluid Extraction
- •References
- •8. Qualitative and Quantitative Methods of Phytochemical Analysis
- •8.1 Introduction
- •8.2 Phytochemical Screening Through Chemical Test
- •8.2.1 Alkaloids
- •8.2.2 Glycosides
- •8.2.3 Flavanoids
- •8.2.4 Tannins
- •8.2.5 Saponins
- •8.2.6 Terpenoids
- •8.2.7 Carbohydrates
- •8.3 Quantitative Methods of Phytochemical Analysis
- •8.3.1 Determination of total phenolic content
- •8.3.1.1 Folin-Ciocalteu Method
- •8.3.2 Determination of Total Flavonoid Content
- •8.3.2.1 Determination of Tannins
- •8.3.2.2 Estimation of Total Tannin Content
- •8.3.2.3 Determination of Total Alkaloid
- •8.3.2.4 Determination of Carbohydrates
- •8.3.2.5 Determination of Protein
- •8.3.3 Analytical Parameters for Fixed Oils and Waxes
- •8.4 Analytical Techniques In Phytochemical Analysis
- •8.5 Conclusion
- •References
- •9. Modern Analytical Techniques for Quality Control and Chemical Identification of Phytochemicals
- •9.1 Introduction
- •9.1.1 Background and Significance of Phytochemicals
- •9.1.2 Importance of Quality Control and Chemical Identification
- •9.1.3 Overview of Modern Analytical Techniques
- •9.2 Chromatographic Techniques
- •9.2.1 High-performance Liquid Chromatography
- •9.2.2 Gas Chromatography
- •9.2.3 Thin-layer Chromatography and High-performance Thin-layer Chromatography
- •9.3 Spectroscopic Techniques
- •9.3.1 Ultraviolet-visible Spectroscopy
- •9.3.2 Fourier Transform Infrared Spectroscopy
- •9.3.3 Nuclear Magnetic Resonance
- •9.4 Mass Spectrometry
- •9.4.1 Structural Elucidation of Phytochemicals by Mass Spectrometry
- •9.4.2 Quantitative Analysis and Quality Control Measures
- •9.4.2.1 Quantitative Analysis for Phytochemicals
- •9.4.2.1.1 External Calibration
- •9.4.2.1.2 Internal Standardization
- •9.4.2.1.3 Isotope Dilution Analysis
- •9.4.2.2 Quality Control Measures for Phytochemicals
- •9.5 Hyphenated Techniques
- •9.5.1 LC-MS and GC-MS Applications in Phytochemical Analysis
- •9.5.2 LC-NMR-MS for Comprehensive Structural Elucidation
- •9.6 Chemometric Tools and Data Analysis
- •9.6.1 Multivariate Analysis Techniques and Quality Control and Pattern Recognition Methods
- •9.7 Advanced Technologies
- •9.7.1 Metabolomics in Phytochemical Analysis and Molecular Imaging Techniques
- •9.8 Challenges and Future Perspectives
- •9.8.1 Current Challenges in Phytochemical Analysis
- •9.8.2 Future Directions and Emerging Technologies
- •9.9 Conclusion
- •References
- •10. Classification and Therapeutic Applications of Plant Secondary Metabolites
- •10.1 Introduction
- •10.1.1 Types of PSMs
- •10.1.2 Functions of PSMs
- •10.2 Classification of PSMs
- •10.2.1 Alkaloids
- •10.2.2 Terpenoids
- •10.2.3 Phenolic Compounds
- •10.2.4 Glycosides
- •10.2.5 Tannins
- •10.2.6 Saponins
- •10.3 Biosynthetic Pathways
- •10.4 Environmental Factors Affecting PSMs
- •10.5 Genetic Factors Affecting PSMs
- •10.6 Role of Enzymes in Plant Secondary Metabolite Production
- •10.7 PSMs Therapeutic Applications
- •10.7.1 Antimicrobial Properties
- •10.7.2 Anticancer Potential
- •10.7.3 Anti-inflammatory and Immunomodulatory Effects
- •10.7.4 Neuroprotective and Cognitive Benefits
- •10.7.5 Cardiovascular Health Benefits
- •10.7.6 Antioxidant and Antiaging Effects
- •10.8 Safety and Toxicity Considerations
- •10.8.1 Plant Toxicity
- •10.8.2 Potential Health Risks
- •10.9 Standardization of Herbal Medicine Using PSMs
- •10.9.1 Methods Used for Standardization of Herbal Medicines
- •10.9.2 Obstacles in Standardizing Herbal Medicines Related to PSMs
- •10.9.3 Variations in PSMs that Affect the Standardization Process
- •10.10 Conclusion
- •References
- •11. Isolation, Fractionation, and Purification of Natural Products
- •11.1 Introduction
- •11.2 Extraction
- •11.2.1 Consideration for the Extraction
- •11.2.2 Factors Affecting Extraction
- •11.2.3 Selection of Appropriate Solvent for Extraction
- •11.3 Extraction Methods/Technique
- •11.3.1 Maceration
- •11.3.2 Percolation
- •11.3.3 Soxhlet Extraction
- •11.3.4 Supercritical Fluid Extraction
- •11.3.5 Microwave-assisted Extraction
- •11.3.6 Pressurized Liquid Extraction
- •11.3.7 Ultrasound-assisted Extraction
- •11.3.8 Extraction with Ionic liquids
- •11.3.9 Accelerated (Pressurized) Solvent Extraction
- •11.4 Fractionation Techniques
- •11.4.1 Liquid–Liquid Fractionation
- •11.4.2 Chromatographic Techniques
- •11.4.2.1 Column Chromatography
- •11.4.2.2 Thin Layer Chromatography
- •11.4.2.3 High-performance Liquid Chromatography
- •11.4.2.4 Vacuum Liquid Chromatography
- •11.4.3 With Advances in Fractionation Techniques to Isolate and Purify Natural Products (e.g. counter-current chromatography)
- •11.5 Purification
- •11.5.1 Importance and Goals of Purification
- •11.5.2 Crystallization, Distillation, and Sublimation
- •11.5.2.1 Crystallization
- •11.5.2.2 Distillation
- •11.5.2.3 Sublimation
- •11.5.3 Advanced Purification Techniques
- •11.5.3.1 Flash Chromatography
- •11.5.3.2 Preparative HPLC
- •References
- •12. Pharmacological Screening of Drugs from Natural Sources
- •12.1 Introduction
- •12.2 Pharmacological Approaches
- •12.2.1 Discovery of Biologically Active Compounds
- •12.2.2 Pharmacological Screening Methods
- •12.2.2.1 In vivo Models
- •12.2.2.1.1 Screening Models for Cardiovascular System Diseases
- •12.2.2.1.2 Screening Models for Nervous System Diseases
- •12.2.2.1.3 Screening Models for Respiratory System Diseases
- •12.2.2.1.4 Screening Models for Urinary System Diseases
- •12.2.2.1.5 Screening Models for Musculoskeletal Diseases
- •12.2.2.1.6 Screening Models for Digestive System Diseases
- •12.2.2.1.7 Screening Models for Metabolic Diseases
- •12.2.2.1.8 Screening Models for Cancer
- •12.2.2.1.9 Screening Models for Immunomodulatory Diseases
- •12.2.2.1.10 Screening Models for Ophthalmic Diseases
- •12.2.2.1.11 Screening Models for Anti-inflammatory Activity
- •12.2.2.1.13 Screening Models for Antipyretic Activity
- •12.2.2.1.14 Screening Models for Dermal Diseases
- •12.2.2.2 In Vitro Models
- •12.2.2.2.1 Isolated Organs
- •12.2.2.2.2 Culture Methods
- •12.2.2.2.3 Enzyme Inhibition and Receptor Binding Assay
- •12.3 Conclusion
- •References
- •13. Biosynthetic Pathways of Phytopharmaceuticals
- •13.1 Introduction
- •13.1.1 Biosynthetic Pathway
- •13.1.2 History
- •13.1.3 Gross Idea
- •13.1.4 Milestones
- •13.2 Introduction to Primary and Secondary Metabolites
- •13.2.1 Primary Metabolites
- •13.2.2 Roles and Significance
- •13.2.2.1 Primary Metabolites
- •13.2.2.2 Secondary Metabolites
- •13.3 General Metabolic/Synthetic Pathway Which Shows from CO2 to Different Primary and Secondary Metabolite Formation
- •13.4 Enzymes
- •13.4.1 Functions of Enzymes
- •13.4.2 Catalytic Mechanism
- •13.5 Role of Enzymes in Biosynthetic Pathways
- •13.5.1 Basic Metabolic Pathway and Their Utilization to Produce Secondary Metabolite
- •13.5.1.1 Basic Metabolic Pathways
- •13.5.1.2 Utilization for Secondary Metabolites
- •13.5.1.4 Keto-enol Tautomerism
- •13.6 Other Structural Modifications
- •13.6.1 Isomerization
- •13.6.2 Hydrogenation and Dehydrogenation
- •13.6.3 Ring-Opening and Ring-closing Reactions
- •13.6.4 Functional Group Inter-conversion
- •13.6.5 Modern Techniques in Structural Elucidation
- •13.6.6 Importance in Drug Design and Synthesis
- •13.6.7 Intermediates and End Products in Secondary Metabolic Pathways
- •13.6.8 Integration of Pathways
- •13.7 Shikimic Acid Pathway for Biosynthesis of Aromatic Amino Acids
- •13.10 Acetate Mevalonate Pathways for Biosynthesis of Fatty Acyl-CoA
- •References
- •14. Pharmaceutical Aids of Natural Origin
- •14.1 Introduction
- •14.2 Some Industrially Important Pharmaceutical Aids
- •14.2.1 Acacia Gum
- •14.2.2 Agar-agar
- •14.2.3 Albumin
- •14.2.4 Alginates
- •14.2.5 Anthocyanidins
- •14.2.6 Cellulose
- •14.2.7 Chitosan
- •14.2.8 Cochineal
- •14.2.9 Curcumin
- •14.2.10 Gelatin
- •14.2.11 Gellan Gum
- •14.2.12 Guar Gum
- •14.2.13 Gum Karaya
- •14.2.14 Gum Tragacanth
- •14.2.15 Inulin
- •14.2.16 Lawsone
- •14.2.17 Locust Bean Gum
- •14.2.18 Pectins
- •14.2.19 Starch
- •14.2.20 Tamarind Gum
- •14.2.21 Xanthan Gum
- •14.3 Conclusion
- •References
- •15. Nutraceuticals and Cosmeceuticals
- •15.1.1 Definition of Nutraceuticals and Cosmeceuticals
- •15.1.2 Historical Overview
- •15.1.3 Significance in Modern Healthcare and Beauty Industries
- •15.2 Nutraceuticals
- •15.2.1 Definition and Classification
- •15.2.1.1 Functional Foods
- •15.2.1.2 Dietary Supplements
- •15.2.2 Key Components and Ingredients
- •15.2.2.1 Vitamins and Minerals
- •15.2.2.2 Antioxidants
- •15.2.2.3 Omega-3 Fatty Acids
- •15.2.2.4 Probiotics
- •15.2.3 Health Benefits
- •15.2.3.1 Nutraceutical in Disease Prevention
- •15.2.3.2 Immune System Support
- •15.2.3.3 Cognitive Health
- •15.2.3.4 Anti-inflammatory Effects
- •15.3 Cosmeceuticals
- •15.3.1 Definition and Classification
- •15.3.1.1 Skin Cosmeceuticals
- •15.3.1.2 Creams Cosmeceuticals
- •15.3.1.3 Hair Cosmeceuticals
- •15.3.1.4 Antiaging Cosmeceuticals
- •15.3.2 Active Ingredients
- •15.3.2.1 Retinoid
- •15.3.2.2 Peptide
- •15.3.2.3 Hyaluronic Acid
- •15.3.2.4 α-Hydroxy Acids and β-Hydroxy Acids
- •15.3.3 Beauty and Dermatological Benefits
- •15.3.3.1 Wrinkle Reduction
- •15.3.3.2 Moisturization and Hydration
- •15.3.3.3 Sun Protection and Acne Management
- •15.4 Synergies Between Nutraceuticals and Cosmeceuticals
- •15.4.1 Nutraceutical and Cosmeceutical (Nutra-cosmetical)
- •15.4.2 Internal and External Approaches to Health and Beauty
- •15.4.3 Complementary Benefits
- •15.4.3.1 Skin Health from Within
- •15.4.3.2 Holistic Approaches to Beauty and Wellness
- •15.5 Regulatory Considerations
- •15.5.1 FDA Guidelines for Nutraceuticals
- •15.5.2 Cosmetic Regulations and Approvals
- •15.5.3 Challenges and Opportunities in Compliance
- •15.6 Future Trends and Innovations
- •15.6.1 Advances in Nutraceutical Research
- •15.6.2 Cutting-edge Cosmeceutical Technologies
- •15.6.3 Market Trends and Consumer Preferences
- •15.7 Conclusion
- •References
- •16. Pesticides and Allergens
- •16.1 Introduction
- •16.2 Natural Pesticide/Biopesticides and Natural Anti-allergens: Source, Bioactive Substances and Applications
- •16.2.1 Natural Pesticides/Biopesticides
- •16.2.1.1 Plant-based Biopesticides
- •16.2.1.2 Insect-based Biopesticides
- •16.2.1.3 Marine-based Biopesticides
- •16.2.1.4 Animal-based Biopesticides
- •16.2.1.5 Microorganism-based Biopesticides
- •16.2.2 Natural Anti-allergens
- •16.2.2.1 Plant-based Anti-allergens
- •16.2.2.2 Insect-based Anti-allergens
- •16.2.2.3 Marine-based Anti-allergens
- •16.2.2.4 Animal-based Anti-allergens
- •16.2.2.5 Microorganism-based Anti-allergens
- •16.3 Pharmacological Mechanism and Toxicity Profile of Some Common Natural Pesticides and Anti-allergens
- •16.3.1 Natural Pesticides or Biopesticides
- •16.3.1.1 Azadirachtin
- •16.3.1.2 Abamectin
- •16.3.1.3 Nicotine
- •16.3.1.4 Bacillus thuringiensis (Bt)
- •16.3.1.5 Ryania
- •16.3.1.6 Spinosad
- •16.3.1.7 Pyrethrins
- •16.3.1.8 Rotenone
- •16.3.2 Pharmacological Mechanism and Toxicity of Natural Anti-allergens
- •16.3.2.1 Tussilagone
- •16.3.2.2 Mangiferin
- •16.3.2.3 Shikonin
- •16.3.2.4 Okicamelliaside
- •16.4 Global Market Surveillance of Biopesticides and Anti-allergens
- •16.5 Commercial Production and Formulations of Natural Pesticides and Anti-allergens
- •16.5.1 Commercial Production of Natural Pesticides
- •16.6 Regulatory Aspects for Quality Control of Pesticides and Anti-allergens
- •16.6.1 Regulatory Standard for Pesticides
- •16.6.2 The Regulatory Standard for Anti-allergens
- •16.7 Future Prospects and Opportunities
- •Acknowledgments
- •Conflict of Interest
- •Funding
- •References
- •17. Comparative Phytochemistry and Chemotaxonomy
- •17.1 Introduction
- •17.2 Chemotaxonomy
- •17.3 Chemical Markers in Chemotaxonomy
- •17.3.1 Primary Metabolites
- •17.3.2 Secondary Metabolites
- •17.3.2.1 Glycosides
- •17.3.2.2 Alkaloids
- •17.3.2.3 Terpenoids
- •17.3.2.4 Phenolic Compounds
- •17.4 Methods in Chemotaxonomy
- •17.4.1 Chromatography
- •17.4.2 Spectroscopy
- •17.5 Phytochemical Approach in Chemotaxonomy
- •17.5.1 Fatty Acids
- •17.5.2 Alkaloids
- •17.5.3 Phenolic Compounds
- •17.5.4 Essential Oils
- •17.5.5 Glycosides
- •17.5.6 Lignans
- •17.6 Limitations of Chemotaxonomy
- •17.7 Conclusion
- •References
- •18. Medicinal Plant Biotechnology
- •18.1 Introduction
- •18.2 Plant Tissue Culture
- •18.2.1 History of Plant Cell Culture Technology
- •18.2.2 Nutritional Requirements and Cultural Media
- •18.2.3 Plant Tissue Culture Laboratory Requirements
- •18.2.4 Micropropagation
- •18.2.5 Types of Culture
- •18.2.6 Synthetic Seed or Artificial Seed
- •18.2.7 In-Vitro Plant Germplasm Conservation
- •18.2.8 Plant Cell Immobilization
- •18.2.8.1 Methods of Immobilization
- •18.2.9 Biotransformation
- •18.2.10 Applications of Plant Tissue Culture
- •18.3 Genetic Engineering (Recombinant DNA Technology)
- •18.3.1 Restriction Endonuclease
- •18.3.2 Vectors as Carriers of Transgene
- •18.3.3 Methods of Gene Transfer
- •18.3.3.1 Direct Gene Transfer Methods
- •18.3.3.2 Indirect Gene Transfer Methods
- •18.3.4 Applications of Genetic Engineering
- •18.4 Conclusion
- •References
- •19. Marine Pharmacognosy
- •19.1 Introduction
- •19.1.1 Exploring Marine Organisms for Bioactive Compounds
- •19.1.2 Importance of Marine Organism in Drug Discovery
- •19.2 Marine Ecosystems and Biodiversity
- •19.2.1 Types of Marine Ecosystems
- •19.2.2 Biodiversity in Marine Environments
- •19.2.3 Adaptations and Survival Strategies
- •19.2.4 Ecosystem Services Provided by Marine Biodiversity
- •19.2.5 Biodiversity Threats and Conservation
- •19.3 Bioactive Compounds from Marine Microorganisms
- •19.3.1 Microbial Diversity in the Marine Environment
- •19.3.2 Isolation and Characterization Techniques
- •19.3.3 Pharmaceutical Applications
- •19.4 Marine Algae and Their Medicinal Potential
- •19.4.1 Diversity of Marine Macroalgae
- •19.4.1.1 Cyanobacteria as Marine Microalgae
- •19.4.1.2 Marine Macroalgae
- •19.4.2 Bioactive Compounds and Their Applications
- •19.4.2.1 Pigments
- •19.4.2.1.1 Polyunsaturated Fatty Acids
- •19.4.2.2 Proteins
- •19.5 Marine Invertebrates and Its Bioactive
- •19.5.1 Sponges (Phylum Porifera)
- •19.5.2 Molluscs
- •19.5.3 Echinoderms
- •19.6 Extraction Process and Characterization Techniques
- •19.6.1 Collecting and Processing of Marine Compounds
- •19.6.2.1 Supercritical Water Extraction
- •19.6.2.2 Supercritical Fluid Extraction
- •19.6.2.3 Solid-phase Extraction
- •19.6.2.4 Microwave-assisted Extraction
- •19.6.3 Analytical Tools and Technologies
- •19.6.3.1 Biological Screening
- •19.6.3.2 Thin-layer Chromatography Analysis
- •19.6.3.3 Nuclear Magnetic Resonance Analysis
- •19.6.3.4 Mass Spectroscopy
- •19.7 Pharmacological Activities of Marine-derived Compounds
- •19.7.1 Anticancer Properties of Marine Compounds
- •19.7.1.1 Marine Plants
- •19.7.1.1.1 Macroalgae (Seaweed)
- •19.7.1.1.2 Microalgae
- •19.7.1.2 Marine Fungi
- •19.7.1.3 Marine Bacteria
- •19.7.1.4 Softcorals
- •19.7.2 Neuroprotective and Neuropharmacological Effects
- •19.7.2.1 Parkinson’s Disease
- •19.7.2.1.1 Fucoidan
- •19.7.2.1.2 Seaweeds
- •19.7.2.1.3 Astaxanthin
- •19.7.2.2 Alzheimer’s Disease
- •19.7.2.2.1 Hymenialdisine
- •19.7.2.2.2 Cerebrosides
- •19.8 Preclinical and Clinical Studies of Marine Microorganisms
- •19.8.1 Aplidin (Plitidepsin)
- •19.8.2 Bryostatin-1
- •19.8.3 Dolastatin 10 (IMMU-110)
- •19.8.4 Halaven (Eribulin)
- •19.8.5 Squalamine
- •19.8.6 Lurbinectedin
- •19.9 Marketed Marine Drug Product
- •19.10 Future Prospects
- •19.10.1 Advancements in Marine Natural Product Research
- •19.10.2 Overcoming Challenges in Sustainable Marine Development
- •19.11 Conclusion
- •References
- •20. Molecular Pharmacognosy
- •20.1 Introduction
- •20.1.1 History and Evolution of Pharmacognosy
- •20.1.2 Current Trends in Pharmacognosy
- •20.1.3 Scope and Objectives
- •20.2 Molecular Biology Techniques in Pharmacognosy
- •20.2.1 DNA Extraction, Polymerase Chain Reaction, Sequencing, and Cloning
- •20.2.2 Significance of Different Molecular Biology Techniques
- •20.3 Molecular Genetics and Genomics of Medicinal Plants
- •20.3.1 Genomics of Medicinal Plants
- •20.3.1.1 Genome Evolution
- •20.3.1.2 Genome Duplication
- •20.3.1.3 Examining the Molecular Genetic Basis for the Economic Features of Medicinal Herbs Using Whole Genome Sequences
- •20.3.1.4 Transcriptome Analysis
- •20.3.1.5 Case Studies of Herbal Genomics
- •20.3.2 Genetics
- •20.3.2.1 Novel Technologies in Genetics and Biotechnology to Evaluate Genetic Multiplicity and Analyze Genomic and Transcriptomic Data
- •20.4 PTC of Medicinal Plants
- •20.4.1 Direct Applications of PTC
- •20.4.1.1 Mass Propagation
- •20.4.1.2 Germplasm Conservation
- •20.4.1.3 Secondary Metabolite Production
- •20.4.1.4 Genetic Improvement
- •20.4.1.5 Accelerated Breeding Programs
- •20.4.2 Indirect Applications of Plant Tissue Culture
- •20.4.2.1 Ploidy Engineering
- •20.5 Molecular Biosynthesis and Metabolomics of Medicinal Plants
- •20.5.1 Importance and Application of Metabolomics in Medicinal Plant Research
- •20.5.2 Metabolomics Techniques and Analytical Tools
- •20.6 Molecular Pharmacology and Toxicology of Medicinal Plants
- •20.6.1 Pharmacology of Medicinal Plants
- •20.6.1.1 Phytochemical Analysis
- •20.6.1.2 Bioassays
- •20.6.1.3 Receptor Binding Studies
- •20.6.1.4 Pharmacodynamics, Pharmacokinetics, and Clinical Trials
- •20.6.2 Toxicology of Medicinal Plants
- •20.6.2.1 In Vivo Toxicity Studies
- •20.6.2.2 In Vitro Toxicity Assays
- •20.6.2.3 Safety Pharmacological Studies
- •20.6.2.4 Risk Assessment
- •20.7 Mechanism of Action, Efficacy, and Toxicity of Plant-derived Drugs
- •20.8 Conclusion and Future Prospects
- •References
- •21. Clinical Pharmacognosy
- •21.1 Introduction
- •21.2 Pharmacognosy
- •21.2.1 Emerging Areas in Pharmacognosy
- •21.2.1.1 Forensic Pharmacognosy
- •21.2.1.2 Molecular Pharmacognosy
- •21.2.1.3 Ecopharmacognosy
- •21.2.2 Function of Pharmacognosy in Healthcare System
- •21.3 Clinical Pharmacognosy
- •21.3.1 Role of Clinical Pharmacognosy in Healthcare System
- •21.3.2 Drug Interaction Studies on Botanicals and Dietary Supplements
- •21.3.2.1 Concept of Drug Interaction
- •21.3.2.1.1 Risk Factors for Drug Interactions
- •21.3.2.1.2 Effect of Dietary Supplements and Botanicals on Drug
- •21.3.2.1.3 Effect of Drugs on Dietary Supplements and Botanicals
- •21.3.2.2 Drug Interaction with Botanicals and Dietary Supplements
- •21.3.2.2.1 Examples of Drug Interaction with Botanicals and Dietary Supplements
- •21.3.3.1 Natural Allergenic Extracts: Production and Quality Control
- •21.3.3.2 Methods for the Quality Control of Allergenic Extracts with their Advantages and Disadvantages
- •21.3.3.3 Allergenic Extracts for Diagnosis and Treatment (Table 21.3)
- •21.4 Clinical Studies on Botanicals and Dietary Supplements
- •21.4.1 Phase I, II, III, and IV Trial on Botanicals, and Dietary Supplements with Example
- •21.5 Clinical Pharmacokinetics
- •21.5.1 Clinical Support of the Herbal-drug Interaction Caused by the Blockage of Transporters and Drug-metabolizing Enzymes
- •21.5.1.1 Hydrastis Canadensis
- •21.5.1.2 Kava Kava
- •21.6 Phytoequivalence
- •21.7 Future Prospects of Clinical Pharmacognosy
- •21.8 Conclusion
- •References
- •Index

Contents xi
12 Pharmacological Screening of Drugs from
Natural Sources 235
Jayesh D. Kadam, Adaeze L. Onugwu,
Yogesh A. Kulkarni
12.1 Introduction 235
12.2 Pharmacological Approaches 235
12.2.1 Discovery of Biologically Active
Compounds 235
12.2.2 Pharmacological Screening Methods 235
12.2.2.1 In vivo Models 235
12.2.2.2 In Vitro Models 251
12.3 Conclusion 252
References 252
13 Biosynthetic Pathways of
Phytopharmaceuticals 255
Poonam Nilesh Chougule
13.1 Introduction 255
13.1.1 Biosynthetic Pathway 255
13.1.2 History 255
13.1.3 Gross Idea 256
13.1.4 Milestones 256
13.2 Introduction to Primary and Secondary
Metabolites 256
13.2.1 Primary Metabolites 256
13.2.2 Roles and Significance 257
13.2.2.1 Primary Metabolites 257
13.2.2.2 Secondary Metabolites 258
13.3 General Metabolic/Synthetic Pathway
Which Shows from CO2 to Different
Primary and Secondary Metabolite
Formation 259
13.4 Enzymes 260
13.4.1 Functions of Enzymes 260
13.4.2 Catalytic Mechanism 261
13.5 Role of Enzymes in Biosynthetic
Pathways 261
13.5.1 Basic Metabolic Pathway and Their
Utilization to Produce Secondary
Metabolite 261
13.5.1.1 Basic Metabolic Pathways 262
13.5.1.2 Utilization for Secondary Metabolites 262
13.5.1.3 Intermediates and Possible Diversion of
Pathways 262
13.5.1.4 Keto-enol Tautomerism 263
13.6 Other Structural Modifications 263
13.6.1 Isomerization 263
13.6.2 Hydrogenation and Dehydrogenation 263
13.6.3 Ring-Opening and Ring-closing
Reactions 263
13.6.4 Functional Group Inter-conversion 263
13.6.5 Modern Techniques in Structural
Elucidation 263
13.6.6 Importance in Drug Design and Synthesis 264
13.6.7 Intermediates and End Products in Secondary
Metabolic Pathways 264
13.6.8 Integration of Pathways 264
13.7 Shikimic Acid Pathway for Biosynthesis of
Aromatic Amino Acids 265
13.8 Acetate Mevalonate Pathway for Biosynthesis
of Terpenes 266
13.9 Biosynthesis of Aliphatic Amino Acids 268
13.10 Acetate Mevalonate Pathways for
Biosynthesis of Fatty Acyl-CoA 269
References 271
14 Pharmaceutical Aids of Natural Origin 273
Santosh Yele, Ashwini Deshpande, Kanchan
Salgar, Mohan Kalaskar
14.1 Introduction 273
14.2 Some Industrially Important Pharmaceutical
Aids 275
14.2.1 Acacia Gum 275
14.2.2 Agar-agar 275
14.2.3 Albumin 276
14.2.4 Alginates 276
14.2.5 Anthocyanidins 277
14.2.6 Cellulose 277
14.2.7 Chitosan 278
14.2.8 Cochineal 278
14.2.9 Curcumin 279
14.2.10 Gelatin 279
14.2.11 Gellan Gum 279
14.2.12 Guar Gum 280
14.2.13 Gum Karaya 280
14.2.14 Gum Tragacanth 280
14.2.15 Inulin 281
14.2.16 Lawsone 281
14.2.17 Locust Bean Gum 281
14.2.18 Pectins 282
14.2.19 Starch 282
14.2.20 Tamarind Gum 283
14.2.21 Xanthan Gum 283
14.3 Conclusion 284
References 285
15 Nutraceuticals and Cosmeceuticals 297
Charulata T. Nemade, Nayana S. Baste,
Manisha M. Bihani, Shilpa S. Raut
15.1 Introduction 297
15.1.1 Definition of Nutraceuticals and
Cosmeceuticals 297

xii Contents
15.1.2 Historical Overview 298
15.1.3 Significance in Modern Healthcare and
Beauty Industries 298
15.2 Nutraceuticals 298
15.2.1 Definition and Classification 298
15.2.1.1 Functional Foods 298
15.2.1.2 Dietary Supplements 299
15.2.2 Key Components and Ingredients 299
15.2.2.1 Vitamins and Minerals 299
15.2.2.2 Antioxidants 299
15.2.2.3 Omega-3 Fatty Acids 299
15.2.2.4 Probiotics 300
15.2.3 Health Benefits 300
15.2.3.1 Nutraceutical in Disease Prevention 300
15.2.3.2 Immune System Support 300
15.2.3.3 Cognitive Health 300
15.2.3.4 Anti-inflammatory Effects 300
15.3 Cosmeceuticals 301
15.3.1 Definition and Classification 301
15.3.1.1 Skin Cosmeceuticals 301
15.3.1.2 Creams Cosmeceuticals 301
15.3.1.3 Hair Cosmeceuticals 302
15.3.1.4 Antiaging Cosmeceuticals 302
15.3.2 Active Ingredients 302
15.3.2.1 Retinoid 302
15.3.2.2 Peptide 302
15.3.2.3 Hyaluronic Acid 302
15.3.2.4 α-Hydroxy Acids and β-Hydroxy
Acids 303
15.3.3 Beauty and Dermatological Benefits 303
15.3.3.1 Wrinkle Reduction 303
15.3.3.2 Moisturization and Hydration 303
15.3.3.3 Sun Protection and Acne Management 303
15.4 Synergies Between Nutraceuticals and
Cosmeceuticals 303
15.4.1 Nutraceutical and Cosmeceutical
(Nutra-cosmetical) 303
15.4.2 Internal and External Approaches to Health
and Beauty 304
15.4.3 Complementary Benefits 305
15.4.3.1 Skin Health from Within 305
15.4.3.2 Holistic Approaches to Beauty and
Wellness 305
15.5 Regulatory Considerations 305
15.5.1 FDA Guidelines for Nutraceuticals 306
15.5.2 Cosmetic Regulations and Approvals 306
15.5.3 Challenges and Opportunities in
Compliance 308
15.6 Future Trends and Innovations 308
15.6.1 Advances in Nutraceutical Research 308
15.6.2 Cutting-edge Cosmeceutical
Technologies 310
15.6.3 Market Trends and Consumer
Preferences 311
15.7 Conclusion 311
References 331
16 Pesticides and Allergens 315
Shatabdi Ghose, Bedanta Bhattacharjee,
Damanbhalang Rynjah, Damiki Laloo
16.1 Introduction 315
16.2 Natural Pesticide/Biopesticides and Natural
Anti-Allergens: Source, Bioactive Substances
and Applications 316
16.2.1 Natural Pesticides/Biopesticides 316
16.2.1.1 Plant-based Biopesticides 316
16.2.1.2 Insect-based Biopesticides 318
16.2.1.3 Marine-based Biopesticides 318
16.2.1.4 Animal-based Biopesticides 318
16.2.1.5 Microorganism-based Biopesticides 318
16.2.2 Natural Anti-allergens 319
16.2.2.1 Plant-based Anti-allergens 319
16.2.2.2 Insect-based Anti-allergens 319
16.2.2.3 Marine-based Anti-allergens 319
16.2.2.4 Animal-based Anti-allergens 319
16.2.2.5 Microorganism-based Anti-allergens 320
16.3 Pharmacological Mechanism and Toxicity
Profile of Some Common Natural Pesticides
and Anti-allergens 321
16.3.1 Natural Pesticides or Biopesticides 321
16.3.1.1 Azadirachtin 321
16.3.1.2 Abamectin 321
16.3.1.3 Nicotine 321
16.3.1.4 Bacillus thuringiensis (Bt) 321
16.3.1.5 Ryania 321
16.3.1.6 Spinosad 322
16.3.1.7 Pyrethrins 322
16.3.1.8 Rotenone 322
16.3.2 Pharmacological Mechanism and Toxicity of
Natural Anti-allergens 322
16.3.2.1 Tussilagone 322
16.3.2.2 Mangiferin 322
16.3.2.3 Shikonin 322
16.3.2.4 Okicamelliaside 323
16.4 Global Market Surveillance of Biopesticides
and Anti-allergens 323
16.5 Commercial Production and Formulations of
Natural Pesticides and Anti-allergens 324
16.5.1 Commercial Production of Natural
Pesticides 324
16.5.2 Commercial Production of Natural
Anti-allergens and Formulations of Natural
Pesticides and Anti-allergens 325

Contents xiii
16.5.3 Challenges and Opportunities in the
Commercial Production and Formulations of
Natural Pesticides and Anti-allergens 325
16.6 Regulatory Aspects for Quality Control of
Pesticides and Anti-allergens 326
16.6.1 Regulatory Standard for
Pesticides 326
16.6.2 The Regulatory Standard for
Anti-allergens 326
16.7 Future Prospects and Opportunities 327
Acknowledgments 328
Conflict of Interest 328
Funding 328
References 328
17 Comparative Phytochemistry and
Chemotaxonomy 333
Prathamesh A. Marne, Anil T. Pawar, Amol A.
Tagalpallewar, Akshay M. Baheti
17.1 Introduction 333
17.2 Chemotaxonomy 333
17.3 Chemical Markers in Chemotaxonomy 334
17.3.1 Primary Metabolites 334
17.3.2 Secondary Metabolites 334
17.3.2.1 Glycosides 334
17.3.2.2 Alkaloids 335
17.3.2.3 Terpenoids 335
17.3.2.4 Phenolic Compounds 335
17.4 Methods in Chemotaxonomy 335
17.4.1 Chromatography 335
17.4.2 Spectroscopy 335
17.5 Phytochemical Approach in
Chemotaxonomy 336
17.5.1 Fatty Acids 336
17.5.2 Alkaloids 336
17.5.3 Phenolic Compounds 337
17.5.4 Essential Oils 340
17.5.5 Glycosides 341
17.5.6 Lignans 341
17.6 Limitations of Chemotaxonomy 342
17.7 Conclusion 342
References 342
18 Medicinal Plant Biotechnology 347
Anil T. Pawar, Amol A. Tagalpallewar, Manasi
Mishra, Arti G. Swami, Akshay M. Baheti
18.1 Introduction 347
18.2 Plant Tissue Culture 347
18.2.1 History of Plant Cell Culture
Technology 349
18.2.2 Nutritional Requirements and Cultural
Media 349
18.2.3 Plant Tissue Culture Laboratory
Requirements 353
18.2.4 Micropropagation 355
18.2.5 Types of Culture 355
18.2.5.1 Callus Culture 356
18.2.5.2 Cell Suspension Culture 356
18.2.5.3 Single-cell Culture 356
18.2.5.4 Protoplast Culture 357
18.2.5.5 Organ Culture 358
18.2.5.6 Root Culture 358
18.2.5.7 Leaf Culture 358
18.2.5.8 Flower Bud Culture 358
18.2.5.9 Ovary Culture 358
18.2.5.10 Ovule Culture 358
18.2.5.11 Embryo Culture 359
18.2.5.12 Anther and Pollen Culture (Microspore
Culture) 359
18.2.6 Synthetic Seed or Artificial Seed 359
18.2.7 In-Vitro Plant Germplasm Conservation 359
18.2.8 Plant Cell Immobilization 360
18.2.8.1 Methods of Immobilization 360
18.2.9 Biotransformation 360
18.2.10 Applications of Plant Tissue Culture 361
18.3 Genetic Engineering (Recombinant DNA
Technology) 362
18.3.1 Restriction Endonuclease 362
18.3.2 Vectors as Carriers of Transgene 363
18.3.3 Methods of Gene Transfer 364
18.3.3.1 Direct Gene Transfer Methods 364
Microprojectile Bombardment/
Gene Gun 364
Microinjection 364
18.3.3.2 Indirect Gene Transfer Methods 364
18.3.4 Applications of Genetic Engineering 365
18.4 Conclusion 366
References 366
19 Marine Pharmacognosy 371
Mamta Kumari, Piyushkumar Sadhu, Niyati
Shah, Chitrali Talele
19.1 Introduction 371
19.1.1 Exploring Marine Organisms for Bioactive
Compounds 371
19.1.2 Importance of Marine Organism in Drug
Discovery 371
19.2 Marine Ecosystems and Biodiversity 372
19.2.1 Types of Marine Ecosystems 372
19.2.2 Biodiversity in Marine Environments 372
19.2.3 Adaptations and Survival Strategies 373
19.2.4 Ecosystem Services Provided by Marine
Biodiversity 373
19.2.5 Biodiversity Threats and Conservation 373

xiv Contents
19.3 Bioactive Compounds from Marine
Microorganisms 373
19.3.1 Microbial Diversity in the Marine
Environment 374
19.3.2 Isolation and Characterization
Techniques 374
19.3.3 Pharmaceutical Applications 374
19.4 Marine Algae and Their Medicinal
Potential 375
19.4.1 Diversity of Marine Macroalgae 375
19.4.1.1 Cyanobacteria as Marine Microalgae 375
19.4.1.2 Marine Macroalgae 376
19.4.2 Bioactive Compounds and Their
Applications 376
19.4.2.1 Pigments 376
19.4.2.2 Proteins 377
19.5 Marine Invertebrates and Its Bioactive 378
19.5.1 Sponges (Phylum Porifera) 378
19.5.2 Molluscs 379
19.5.3 Echinoderms 379
19.6 Extraction Process and Characterization
Techniques 380
19.6.1 Collecting and Processing of Marine
Compounds 380
19.6.2 Extraction Process and Characterization
Techniques 380
19.6.2.1 Supercritical Water Extraction 381
19.6.2.2 Supercritical Fluid Extraction 381
19.6.2.3 Solid-phase Extraction 381
19.6.2.4 Microwave-assisted Extraction 381
19.6.3 Analytical Tools and Technologies 382
19.6.3.1 Biological Screening 382
19.6.3.2 Thin-layer Chromatography Analysis 382
19.6.3.3 Nuclear Magnetic Resonance Analysis 382
19.6.3.4 Mass Spectroscopy 382
19.7 Pharmacological Activities of Marine-derived
Compounds 382
19.7.1 Anticancer Properties of Marine
Compounds 382
19.7.1.1 Marine Plants 382
19.7.1.2 Marine Fungi 383
19.7.1.3 Marine Bacteria 383
19.7.1.4 Softcorals 383
19.7.2 Neuroprotective and Neuropharmacological
Effects 384
19.7.2.1 Parkinson’s Disease 384
19.7.2.2 Alzheimer’s Disease 385
19.8 Preclinical and Clinical Studies of Marine
Microorganisms 385
19.8.1 Aplidin (Plitidepsin) 386
19.8.2 Bryostatin-1 386
19.8.3 Dolastatin 10 (IMMU-110) 386
19.8.4 Halaven (Eribulin) 386
19.8.5 Squalamine 386
19.8.6 Lurbinectedin 386
19.9 Marketed Marine Drug Product 386
19.10 Future Prospects 388
19.10.1 Advancements in Marine Natural Product
Research 388
19.10.2 Overcoming Challenges in Sustainable
Marine Development 388
19.11 Conclusion 388
References 389
20 Molecular Pharmacognosy 395
Piyushkumar Sadhu, Mamta Kumari,
Ghanshyam Parmar, Chitrali Talele
20.1 Introduction 395
20.1.1 History and Evolution of
Pharmacognosy 395
20.1.2 Current Trends in Pharmacognosy 396
20.1.3 Scope and Objectives 396
20.2 Molecular Biology Techniques in
Pharmacognosy 396
20.2.1 DNA Extraction, Polymerase Chain Reaction,
Sequencing, and Cloning 397
20.2.2 Significance of Different Molecular Biology
Techniques 397
20.2.3 Different Examples of Molecular Markers,
Barcodes, and Databases for Molecular
Identification and Authentication of
Medicinal Plants 398
20.3 Molecular Genetics and Genomics of
Medicinal Plants 399
20.3.1 Genomics of Medicinal Plants 400
20.3.1.1 Genome Evolution 401
20.3.1.2 Genome Duplication 401
20.3.1.3 Examining the Molecular Genetic Basis for
the Economic Features of Medicinal Herbs
Using Whole Genome Sequences 401
20.3.1.4 Transcriptome Analysis 402
20.3.1.5 Case Studies of Herbal Genomics 402
20.3.2 Genetics 403
20.3.2.1 Novel Technologies in Genetics and
Biotechnology to Evaluate Genetic
Multiplicity and Analyze Genomic and
Transcriptomic Data 403
20.4 PTC of Medicinal Plants 404
20.4.1 Direct Applications of PTC 405
20.4.1.1 Mass Propagation 405
20.4.1.2 Germplasm Conservation 405
20.4.1.3 Secondary Metabolite Production 406
20.4.1.4 Genetic Improvement 406
20.4.1.5 Accelerated Breeding Programs 406

Contents xv
20.4.2 Indirect Applications of Plant Tissue
Culture 406
20.4.2.1 Ploidy Engineering 406
20.5 Molecular Biosynthesis and Metabolomics of
Medicinal Plants 407
20.5.1 Importance and Application of
Metabolomics in Medicinal Plant
Research 407
20.5.2 Metabolomics Techniques and Analytical
Tools 408
20.6 Molecular Pharmacology and Toxicology of
Medicinal Plants 410
20.6.1 Pharmacology of Medicinal
Plants 410
20.6.1.1 Phytochemical Analysis 410
20.6.1.2 Bioassays 410
20.6.1.3 Receptor Binding Studies 410
20.6.1.4 Pharmacodynamics, Pharmacokinetics, and
Clinical Trials 411
20.6.2 Toxicology of Medicinal Plants 411
20.6.2.1 In Vivo Toxicity Studies 411
20.6.2.2 In Vitro Toxicity Assays 411
20.6.2.3 Safety Pharmacological Studies 412
20.6.2.4 Risk Assessment 412
20.7 Mechanism of Action, Efficacy, and Toxicity
of Plant-derived Drugs 412
20.8 Conclusion and Future Prospects 413
References 413
21 Clinical Pharmacognosy 421
Jayesh D. Kadam, Sandip T. Auti
21.1 Introduction 421
21.2 Pharmacognosy 421
21.2.1 Emerging Areas in Pharmacognosy 422
21.2.1.1 Forensic Pharmacognosy 422
21.2.1.2 Molecular Pharmacognosy 422
21.2.1.3 Ecopharmacognosy 422
21.2.2 Function of Pharmacognosy in Healthcare
System 422
21.3 Clinical Pharmacognosy 423
21.3.1 Role of Clinical Pharmacognosy in
Healthcare System 423
21.3.2 Drug Interaction Studies on Botanicals and
Dietary Supplements 423
21.3.2.1 Concept of Drug Interaction 423
21.3.2.2 Drug Interaction with Botanicals and Dietary
Supplements 424
21.3.3 Role of Natural Allergenic Extract in the
Diagnosis of Allergic Conditions 428
21.3.3.1 Natural Allergenic Extracts: Production and
Quality Control 429
21.3.3.2 Methods for the Quality Control of Allergenic
Extracts with their Advantages and
Disadvantages 431
21.3.3.3 Allergenic Extracts for Diagnosis and
Treatment (Table 21.3) 432
21.4 Clinical Studies on Botanicals and Dietary
Supplements 433
21.4.1 Phase I, II, III, IV Trial on Botanicals, and
Dietary Supplements with Example 434
21.5 Clinical Pharmacokinetics 435
21.5.1 Clinical Support of the Herbal-drug
Interaction Caused by the Blockage of
Transporters and Drug-metabolizing
Enzymes 435
21.5.1.1 Hydrastis Canadensis 435
21.5.1.2 Kava Kava 436
21.6 Phytoequivalence 436
21.7 Future Prospects of Clinical
Pharmacognosy 437
21.8 Conclusion 437
References 437
Index 443

List of Contributors
Rahima Amjad
Department of Nutrition and Dietetics
The University of Faisalabad
Faisalabad
Pakistan
Moses Sam Arul Raj
Department of Botany
A.V.V.M. Sri Pushpam College (Autonomous)
Thanjavur, Tamil Nadu
India
Sandip T. Auti
Shobhaben Pratapbhai Patel School of Pharmacy &
Technology Management
SVKM's Narsee Monjee Institute of Management Studies
(Deemed to be University)
Mumbai, Maharashtra
India
Muniappan Ayyanar
Department of Botany
A. V. V. M. Sri Pushpam College (Affiliated to
Bharathidasan University)
Thanjavur, Tamil Nadu
India
Akshay M. Baheti
Department of Pharmaceutical Sciences
School of Health Sciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Nayana S. Baste
Department of Pharmacognosy
SNJB’s Shriman Sureshdada Jain College of Pharmacy
Nashik, Maharashtra
India
Vishal Beldar
Department of Pharmacognosy, School of Pharmacy &
Technology Management
SVKM’s Narsee Monjee Institute of Management Studies
(NMIMS) Deemed-to-be-University
Shirpur, Maharashtra
India
Bedanta Bhattacharjee
School of Pharmaceutical Sciences
Girijananda Chowdhury University, Tezpur Campus
Tezpur, Assam
India
Piyush S. Bafna
Department of Pharmacology
H. R. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Vishal S. Bagul
Department of Pharmacognosy
H. R. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Manisha M. Bihani
Department of Pharmacognosy
Krupanidhi College of Pharmacy
Bengaluru, Karnataka
India
Gajendra Choudhary
School of Pharmacy
Devi Ahilya Vishwavidyalaya
Indore, Madhya Pradesh
India

xviii List of Contributors
Poonam Nilesh Chougule
Ashokrao Mane College of Pharmacy
Peth-Vadgaon, Maharashtra
India
Ashwini Deshpande
SVKM's NMIMS School of Pharmacy & Technology
Management
Hyderabad, Telangana
India
Shahira M. Ezzat
Department of Pharmacognosy
Faculty of Pharmacy
Cairo University
Cairo
Egypt
Mai M. Farid
Department of Phytochemistry and Plant Systematics
National Research Centre
Giza
Egypt
Jineetkumar B. Gawad
Department of Pharmaceutical Chemistry
VIVA Institute of Pharmacy
Virar (E), Maharashtra
India
Shatabdi Ghose
Department of Pharmacology
School of Pharmaceutical Sciences
Girijananda Chowdhury University, Guwahati Campus
Guwahati, Assam
India
Shailendra Gurav
Department of Pharmacognosy
Goa College of Pharmacy
Panaji, Goa
India
Nilambari Gurav
Department of Pharmacognosy
P.E.S's Rajaram and Tarabai Bandekar College
of Pharmacy
Ponda, Goa
India
Muhammad Saad Hashmi
Institute of Food Science and Nutrition
Bahauddin Zakariya University
Multan
Pakistan
Uzma Javaid
Department of Anatomy
Sargodha Medical College
Sargodha
Pakistan
Amna Javed
Department of Nutrition and Dietetics
The University of Faisalabad
Faisalabad
Pakistan
Jayesh D. Kadam
Shobhaben Pratapbhai Patel School of Pharmacy &
Technology Management
SVKM's Narsee Monjee Institute of Management
Studies (NMIMS) (Deemed to be University)
Mumbai, Maharashtra
India
Mohan Kalaskar
Department of Pharmacognosy
R. C. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Rakhi Khabiya
Acropolis Institute of Pharmaceutical Education
and Research
Indore, Madhya Pradesh
India
Zamir G. Khan
Department of Pharmaceutical Chemistry
H. R. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Yogesh A. Kulkarni
Shobhaben Pratapbhai Patel School of Pharmacy &
Technology Management
SVKM’s Narsee Monjee Institute of Management Studies
(NMIMS) Deemed to be University
Mumbai, Maharashtra
India

List of Contributors xix
Mamta Kumari
Department of Pharmacy
Sumandeep Vidyapeeth Deemed to be University
Vaodara, Gujarat
India
Damiki Laloo
Phytochemical Research Laboratory
Department of Pharmacognosy, School of Pharmaceutical
Sciences
Girijananda Chowdhury University, Guwahati Campus
Guwahati, Assam
India
Prathamesh A. Marne
Department of Pharmaceutical Sciences
School of Health Sciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Mona M. Marzouk
Department of Phytochemistry and Plant Systematics
National Research Centre
Giza
Egypt
Rana M. Merghany
Department of Pharmacognosy
Pharmaceutical and Drug Industries Research Institute
National Research Centre
Giza
Egypt
Mughisa Nagori
Mahakal Institute of Pharmaceutical Studies
Ujjain, Madhya Pradesh
India
Charulata T. Nemade
Department of Pharmacognosy
SNJB’s Shriman Sureshdada Jain College of Pharmacy,
Nashik, Maharashtra
India
Manasi R. Nimbalkar
Department of Kriya Sharir,
Ashtang Ayurved Mahavidyalaya
Pune, Maharashtra
India
Ranjeet Nimbalkar
Anubandha Health Care
Comprehensive Cancer Care Clinic
Pune, Maharashtra
India
Adaeze Onugwu
University of Nigeria
Nsukka, Enugu State
Nigeria
Ghanshyam Parmar
Department of Pharmacy
Sumandeep Vidyapeeth Deemed to be University
Vaodara, Gujarat
India
Manasi Mishra
Department of Biosciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Popat Mohite
AETs St. John Institute of Pharmacy and Research
Palghar, Maharashtra
India
Rakesh E. Mutha
Department of Pharmacognosy
H. R. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Deepak M. Patil
Department of Quality Assurance
H. R. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Anil T. Pawar
Department of Pharmaceutical Sciences
School of Health Sciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Abhijeet Puri
AETs St. John Institute of Pharmacy and Research
Palghar, Maharashtra
India

xx List of Contributors
Devyani Rajput
Amity Institute of Pharmacy
Amity University (M.P.) 47005
Shilpa S. Raut
Department of Pharmaceutics
K.K. Wagh College of Pharmacy
Nashik, Maharashtra
India
Damanbhalang Rynjah
School of Pharmaceutical Sciences
Girijananda Chowdhury University, Tezpur Campus
Tezpur, Assam
India
Piyushkumar Sadhu
Department of Pharmacy
Sumandeep Vidyapeeth Deemed to be University
Vaodara, Gujarat
India
Rushikesh P. Said
Institute of Chemical Technology
Mumbai
Marathwada Campus
Jalna, Maharashtra
India
Kanchan Salgar
SVKM's NMIMS School of Pharmacy & Technology
Management
Hyderabad, Telangana
India
Sanjay J. Surana
Department of Pharmacognosy
R. C. Patel Institute of Pharmaceutical Education
and Research
Shirpur, Maharashtra
India
Arti G. Swami
Department of Pharmaceutical Sciences
School of Health Sciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Amol A. Tagalpallewar
Department of Pharmaceutical Sciences
School of Health Sciences and Technology
Dr. Vishwanath Karad MIT World Peace University
Pune, Maharashtra
India
Chitrali Talele
Department of Pharmacy
Sumandeep Vidyapeeth Deemed to be University
Vaodara, Gujarat
India
Santosh U. Yele
Department of Pharmacognosy,
Poona College of Pharmacy
Bharati Vidyapeeth (Deemed to be University)
Pune, Maharashtra
India
Niyati Shah
Department of Pharmacy
Sumandeep Vidyapeeth Deemed to be University
Vaodara, Gujarat
India

Preface
The field of Pharmacognosy, with its roots in ancient practices of medicinal plant use, has evolved into a dynamic
scientific discipline integrating phytochemical analysis,
biotechnological advancements, and clinical applications.
“Pharmacognosy and Phytochemistry: Principles, Techniques, and Applications” provides a comprehensive overview of this multifaceted field. It begins with a historical
exploration of Pharmacognosy and Phytochemistry, detailing the evolution of medicinal plant use and scientific
inquiry. The book covers the classification of crude drugs,
ethnobotany, ethnopharmacology, and complementary
medicinal systems, offering insights into the cultural and
ecological dimensions of plant-based medicines. Practical
aspects such as cultivation, collection, preparation, adulteration, and evaluation of plant drugs are discussed in
detail. The book elucidates methodologies for extracting
bioactive compounds, qualitative and quantitative phytochemical analysis, and advanced analytical techniques for
quality control. It highlights the therapeutic potential of
plant secondary metabolites and the processes of isolation,
purification, and characterization of herbal drugs. Biological screening methods and biosynthetic pathways of
phytopharmaceuticals are explored, alongside pharmaceutical aids, nutraceuticals, cosmeceuticals, pesticides, and
allergens. Comparative Phytochemistry, chemotaxonomy,
and modern plant biotechnology are explored, along with
the emerging field of marine Pharmacognosy. Molecular
and Clinical Pharmacognosy bridge research and clinical
applications, emphasizing the translation of scientific
discoveries into health benefits. This book serves as a
resource for students, researchers, and practitioners, combining traditional knowledge with modern advancements
to provide a holistic understanding of Pharmacognosy and
Phytochemistry.
EDITORS:
UCHENNA E. ODOH
SHAILENDRA S. GURAV
MICHAEL O. CHUKWUMA
July, 2024
Nigeria
Соседние файлы в папке Библиотека им академика М.И. Перельмана
